SCHEMBL2902152

SCHEMBL2902152

CC(=O)Nc1ccc(F)c(C(N)=O)c1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.53
HDAC1 Q13547 3/20 0.50
SIRT2 Q8IXJ6 1/20 0.50
MEN1 O00255 5/20 0.48
KMT2A Q03164 5/20 0.48
ALDH1A1 P00352 4/20 0.48
MAPT P10636 3/20 0.48
HTT P42858 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
CDK1 P06493 1/20 0.45
POLB P06746 2/20 0.45
KDM4E B2RXH2 1/20 0.45
NPC1 O15118 1/20 0.45
GLA P06280 1/20 0.45
TNNI3 P19429 1/20 0.45
TNNT2 P45379 1/20 0.45
RAB9A P51151 1/20 0.45
TNNC1 P63316 1/20 0.45
RUNX1 Q01196 1/20 0.45
CBFB Q13951 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2925453 0.86 HDAC1 (0.61) SMN1; SMN2HDAC1SIRT2MEN1KMT2A
SCHEMBL4078006 0.86 SMN1; SMN2 (0.60) SMN1; SMN2HDAC1MEN1KMT2AALDH1A1
SCHEMBL1655468 0.84 MYC (0.56) SMN1; SMN2HDAC1MEN1KMT2AALDH1A1
SCHEMBL16669803 0.82 ALDH1A1 (0.46) SMN1; SMN2MEN1KMT2AALDH1A1KDM4E
SCHEMBL4405935 0.81 SMN1; SMN2 (0.55) SMN1; SMN2HDAC1MEN1KMT2AALDH1A1
SCHEMBL551783 0.81 SMN1; SMN2 (0.54) SMN1; SMN2SIRT2MEN1KMT2AALDH1A1
SCHEMBL7380689 0.81 SIRT2 (0.55) SMN1; SMN2HDAC1SIRT2MEN1KMT2A
SCHEMBL13254952 0.81 SMN1; SMN2 (0.53) SMN1; SMN2SIRT2MAPTPOLBKDM4E
SCHEMBL17307570 0.80 SMN1; SMN2 (0.50) SMN1; SMN2HDAC1MEN1KMT2AALDH1A1
SCHEMBL863069 0.80 RAB9A (0.58) SMN1; SMN2HDAC1MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2217601-A1 IMIDAZOPYRIDAZINES FOR USE AS PROTEIN KINASE INHIBITORS Centro Nacional de Investigaciones Oncológicas (CNIO) (ES) 2010-08-18 EP disclosed
EP-1959951-B1 HETEROARYL SUBSTITUTED PIPERIDINE DERIVATIVES AS L-CPT1 INHIBITORS HOFFMANN LA ROCHE (CH) 2009-12-23 EP disclosed
WO-2009060197-A1 IMIDAZOPYRIDAZINES FOR USE AS PROTEIN KINASE INHIBITORS CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS (CNIO) (ES) 2009-05-14 WO disclosed